These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 18354415)

  • 1. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
    Chu IM; Hengst L; Slingerland JM
    Nat Rev Cancer; 2008 Apr; 8(4):253-67. PubMed ID: 18354415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein profiling: a possible molecular mechanism to mislocalization and down-expression of p27(Kip1) in tumor cells.
    Guan X; Chen L; Wang J
    Med Hypotheses; 2007; 69(3):580-3. PubMed ID: 17360130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting p27Kip1 protein: its relevance in the therapy of human cancer.
    Borriello A; Bencivenga D; Criscuolo M; Caldarelli I; Cucciolla V; Tramontano A; Borgia A; Spina A; Oliva A; Naviglio S; Della Ragione F
    Expert Opin Ther Targets; 2011 Jun; 15(6):677-93. PubMed ID: 21355788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients.
    Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
    Neurobiol Aging; 2008 Oct; 29(10):1474-84. PubMed ID: 17448572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant p27(Kip1) and its potential effect as hepatocellular gene therapy.
    Lu M; Fei M; Cheng C; Wang Y; He S; Zhao Y; Gao S; Ke Q; Li P; Cui X; Shen A
    Arch Med Res; 2008 Aug; 39(6):573-81. PubMed ID: 18662588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atheroma development in apolipoprotein E-null mice is not regulated by phosphorylation of p27(Kip1) on threonine 187.
    Sanz-González SM; Melero-Fernández de Mera R; Malek NP; Andrés V
    J Cell Biochem; 2006 Mar; 97(4):735-43. PubMed ID: 16229012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.
    Hershko DD
    Cancer; 2008 Apr; 112(7):1415-24. PubMed ID: 18260093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SP1-regulated p27/Kip1 gene expression is involved in terbinafine-induced human A431 cancer cell differentiation: an in vitro and in vivo study.
    Huang CS; Ho WL; Lee WS; Sheu MT; Wang YJ; Tu SH; Chen RJ; Chu JS; Chen LC; Lee CH; Tseng H; Ho YS; Wu CH
    Biochem Pharmacol; 2008 May; 75(9):1783-96. PubMed ID: 18355800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The degradation of p27 and cancer].
    Kotoshiba S; Nakayama K
    Nihon Rinsho; 2005 Nov; 63(11):2047-56. PubMed ID: 16277271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
    Denicourt C; Saenz CC; Datnow B; Cui XS; Dowdy SF
    Cancer Res; 2007 Oct; 67(19):9238-43. PubMed ID: 17909030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational regulation of the tumor suppressor p27(KIP1).
    Vervoorts J; Lüscher B
    Cell Mol Life Sci; 2008 Oct; 65(20):3255-64. PubMed ID: 18636226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart.
    Hauck L; Harms C; An J; Rohne J; Gertz K; Dietz R; Endres M; von Harsdorf R
    Nat Med; 2008 Mar; 14(3):315-24. PubMed ID: 18311148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
    Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
    Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of NF-Y target genes changed by CDKN1B correlate with clinical prognosis in multiple cancers.
    Yamanaka K; Mizuarai S; Eguchi T; Itadani H; Hirai H; Kotani H
    Genomics; 2009 Oct; 94(4):219-27. PubMed ID: 19559782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of the pulmonary metastatic tumors by systemic delivery of the p27 kip1 gene using lyophilized lipid-polycation-DNA complexes.
    Sun X; Zhang HW; Zhang ZR
    J Gene Med; 2009 Jun; 11(6):535-44. PubMed ID: 19326369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
    Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
    Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.
    Shiraso S; Katayose Y; Yamamoto K; Mizuma M; Yabuuchi S; Oda A; Rikiyama T; Onogawa T; Yoshida H; Hayashi H; Ohtsuka H; Motoi F; Egawa S; Kato J; Unno M
    Anticancer Res; 2009 Jun; 29(6):2015-24. PubMed ID: 19528460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.